search
Back to results

Periodontitis and Cardiovascular Events or "PAVE"

Primary Purpose

Cardiovascular Disease, Coronary Heart Disease, Myocardial Infarction

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Periodontal Treatment: SRP
Referral
Sponsored by
University at Buffalo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiovascular Disease focused on measuring Heart attacks, Stroke, Angina

Eligibility Criteria

undefined - 75 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Eligibility: Aged 75 years or less AND 50% or more blockage of at least one artery in the heart, Heart problems in the last 3 years (including previous heart attack), Previous heart bypass surgery, or previous heart angioplasty with or without a stent, AND at least 6 natural teeth present in the mouth AND evidence of mild to severe gum problems. Exclusion: Any of the following: A major illness requiring hospitalization, Renal dialysis, Serum creatinine > 3 mg/dl, Organ transplant recipient requiring immunosuppression medication, Surgery needed in the next 3 years, Chemotherapy in the past 3 years, Head and/or neck radiation at any time in the past, Liver dysfunction, Class IV congestive heart failure, Drug or alcohol abuse, Pacemaker or AICD/defibrillator.

Sites / Locations

  • University at Buffalo

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Periodontal Treatment: SRP

Community Comparator

Arm Description

Comprehensive scaling & root planing and subgingival tissue removal; fluorides applied as appropriate; oral hygiene instructions.

Referral to community dentist with copy of x-rays and letter with diagnosis and recomendations for treatment.

Outcomes

Primary Outcome Measures

Patient outcomes are hospitalized for myocardial infarction (MI), cardiac revascularization, fatal coronary heart disease, unstable angina, and/or hospitalized ischemic stroke.

Secondary Outcome Measures

Full Information

First Posted
August 1, 2003
Last Updated
August 4, 2011
Sponsor
University at Buffalo
Collaborators
National Institute of Dental and Craniofacial Research (NIDCR)
search

1. Study Identification

Unique Protocol Identification Number
NCT00066053
Brief Title
Periodontitis and Cardiovascular Events or "PAVE"
Official Title
Periodontal Intervention for Cardiac Events: A Pilot Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2007
Overall Recruitment Status
Completed
Study Start Date
January 2003 (undefined)
Primary Completion Date
June 2005 (Actual)
Study Completion Date
June 2005 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University at Buffalo
Collaborators
National Institute of Dental and Craniofacial Research (NIDCR)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine if treating periodontal infections (gum problems) will lead to fewer heart problems in patients at high risk for cardiovascular disease.
Detailed Description
There is growing evidence of a strong association between infection and atherosclerosis as well as a specific link between periodontal infection (gum problems) and heart disease. Previous studies have established possible effective treatments of periodontal disease. These treatments may lead to fewer heart events in persons at high risk for cardiovascular disease. In contrast to previous heart disease studies, the primary treatment in this project is directed toward infectious agents at periodontal sites. This project is a pilot randomized clinical trial to test the feasibility of selecting and refining a periodontal infection treatment and examining the effect of that treatment on future heart events. It is a multi-center planning and pilot study involving five investigational centers at the University at Buffalo (lead and overall coordinating center), University of North Carolina, Boston University, Kaiser Permanente/Oregon Health Science University, University of Maryland, and a data coordinating center at the University of North Carolina. Central microbiology and cytokine laboratories and a biologic specimen bank are also included. A team of cardiologists, periodontists, epidemiologists, infectious disease specialists, biostatisticians, research nurses in periodontics and cardiology, and data managers has been assembled to accomplish the research with a careful, cost-effective approach. The ultimate goal is to develop a definitive randomized clinical trial that will include about 4,000 participants from approximately 15 centers across the United States

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Disease, Coronary Heart Disease, Myocardial Infarction, Cerebrovascular Accident
Keywords
Heart attacks, Stroke, Angina

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
303 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Periodontal Treatment: SRP
Arm Type
Experimental
Arm Description
Comprehensive scaling & root planing and subgingival tissue removal; fluorides applied as appropriate; oral hygiene instructions.
Arm Title
Community Comparator
Arm Type
Active Comparator
Arm Description
Referral to community dentist with copy of x-rays and letter with diagnosis and recomendations for treatment.
Intervention Type
Procedure
Intervention Name(s)
Periodontal Treatment: SRP
Other Intervention Name(s)
Treatment of periodontal infections.
Intervention Description
Scaling and root planing. Subgingival tissue removal. Fluorides as needed. Oral hygiene instructions. Oral hygiene instructions.
Intervention Type
Procedure
Intervention Name(s)
Referral
Primary Outcome Measure Information:
Title
Patient outcomes are hospitalized for myocardial infarction (MI), cardiac revascularization, fatal coronary heart disease, unstable angina, and/or hospitalized ischemic stroke.
Time Frame
One year

10. Eligibility

Sex
All
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Eligibility: Aged 75 years or less AND 50% or more blockage of at least one artery in the heart, Heart problems in the last 3 years (including previous heart attack), Previous heart bypass surgery, or previous heart angioplasty with or without a stent, AND at least 6 natural teeth present in the mouth AND evidence of mild to severe gum problems. Exclusion: Any of the following: A major illness requiring hospitalization, Renal dialysis, Serum creatinine > 3 mg/dl, Organ transplant recipient requiring immunosuppression medication, Surgery needed in the next 3 years, Chemotherapy in the past 3 years, Head and/or neck radiation at any time in the past, Liver dysfunction, Class IV congestive heart failure, Drug or alcohol abuse, Pacemaker or AICD/defibrillator.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sara G Grossi, DDS, MS
Organizational Affiliation
University at Buffalo
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Thomas E van Dyke, DDS,MS
Organizational Affiliation
Goldman School of Dental Medicine, Boston, MA
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
John C Gunsolley, DDS,MS
Organizational Affiliation
University of Maryland, Dept. of Periodontics, Baltimore, MD
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
James D Beck, Ph.D
Organizational Affiliation
University of NC, School of Dentistry, Chapel Hill, NC
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lloyd E Chambless, PhD,
Organizational Affiliation
University of NC, Dept. of Biostatistics, Chapel Hill, NC
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Steven Offenbacher, DDS,PhD,MMSc
Organizational Affiliation
University of NC, Comprehensive Cntr. for Inflammatory Diseases, Chapel Hill, NC
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Theresa Madden, DDS, PhD
Organizational Affiliation
Oregon Health and Science University, Portland, OR
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Gerardo Maupome, PhD
Organizational Affiliation
Kaiser-Permanente Center for Health Research, Portland, OR
Official's Role
Principal Investigator
Facility Information:
Facility Name
University at Buffalo
City
Buffalo
State/Province
New York
ZIP/Postal Code
14214
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Periodontitis and Cardiovascular Events or "PAVE"

We'll reach out to this number within 24 hrs